The Valley Desk

NCT06177067 · Interventional trial

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

Overall registry status Recruiting

Phase 1

Conditions Acute Leukemia of Ambiguous Lineage, Refractory Acute Myeloid Leukemia, Relapsed Acute Myeloid Leukemia

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov